Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
novartis
5
×
gene therapy
national
national top stories
cancer
genentech
roche
san francisco top stories
biogen
boston blog main
boston top stories
car-t
clinical trials
crispr
deals
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
new york top stories
pfizer
san francisco blog main
zolgensma
acquisitions
acute lymphoblastic leukemia
administration
advanced therapies
alzheimer's
amgen
atmp
avapritinib
avexis
bellicum pharmaceuticals
billy dunn
biomarin pharmaceutical
biontech
What
therapy
5
×
fda
gene
drug
new
patients
access
address
advanced
approval
approved
approves
atrophy
becker
billions
bio
blueprint
cancer
capacity
car
carries
cell
certain
chemistry
cmc
consistent
consolidation
controls
crispr
daily
designed
dollars
eaton
ensure
evrysdi
falcon
focus
friday
genetic
green
Language
unset
Current search:
biotech
×
novartis
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More